Sugi Predict

Sugi Predict / Compounds / SCHEMBL196641

SCHEMBL196641

SCHEMBL196641

CN(C)c1ccnc(-c2cc(N(C)C)ccn2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ CHRM5 P08912 1/20 0.50
▸ CHKA P35790 1/20 0.50
▸ CCR1 P32246 2/20 0.48
▸ CCR5 P51681 2/20 0.48
▸ CCR8 P51685 2/20 0.48
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ ADRA1D P25100 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ ADRA1B P35368 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ GRIN2B Q13224 1/20 0.44
▸ GRIN2C Q14957 1/20 0.44
▸ GRIN3A Q8TCU5 1/20 0.44
▸ TERT O14746 1/20 0.43
▸ APP P05067 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966923 0.88 KDM4E (0.54) ALDH1A1KDM4ECCR1CCR5CCR8
SCHEMBL30636788 0.88 KDM4E (0.54) ALDH1A1KDM4ECCR1CCR5CCR8
SCHEMBL21386837 0.84 KDM4E (0.42) ALDH1A1KDM4ECHRM5CHKACCR1
SCHEMBL1716712 0.83 ASIC3 (0.53) ALDH1A1KDM4EGRIN2DGRIN3BCHRM1
SCHEMBL30345721 0.83 ASIC3 (0.53) ALDH1A1KDM4EGRIN2DGRIN3BCHRM1
SCHEMBL23894718 0.80 HRH4 (0.48) ALDH1A1KDM4ECHKACCR1CCR5
SCHEMBL4311559 0.79 KDM4E (0.38) ALDH1A1KDM4ECHRM5CHKACCR1
SCHEMBL4313244 0.79 KDM4E (0.41) ALDH1A1KDM4ECHRM5CHKACCR1
SCHEMBL13360717 0.79 CYP1A2 (0.57) ALDH1A1KDM4EGRIN2DGRIN3BCHRM1
SCHEMBL2115738 0.79 KDM4E (0.49) ALDH1A1KDM4ECHRM5CHKAGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109696-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2026-04-23 — — US disclosed
US-20260078116-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2026-03-19 — — US disclosed
EP-4658647-A1 TRICYCLIC AZEPINONE DERIVATIVES AS SYSTEM XC INHIBITORS UCB Biopharma SRL (BE) 2025-12-10 — — EP disclosed
US-20250074925-A1 RARE EARTH COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2025-03-06 — — US disclosed
WO-2024160722-A1 TRICYCLIC AZEPINONE DERIVATIVES AS SYSTEM XC INHIBITORS UCB Biopharma SRL (BE) 2024-08-08 — — WO disclosed
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 — — EP disclosed
US-11819835-B2 Catalyst for contaminant reduction and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-11-21 — — US disclosed
US-11819835-B2 Catalyst for contaminant reduction and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-11-21 — — US disclosed
US-11819835-B2 Catalyst for contaminant reduction and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-11-21 — — US disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 — — WO disclosed
US-6618934-B1 Method of manufacturing small volume in vitro analyte sensor THERASENSE, INC. 2003-09-16 — — US disclosed
US-6592745-B1 Analytical sensors for the detection of bioanalytes in a small volume sample; to monitor glucose in diabetic patients and lactate during critical care THERASENSE, INC. 2003-07-15 — — US disclosed
US-6591125-B1 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator THERASENSE, INC. 2003-07-08 — — US disclosed
US-6461496-B1 BLOOD GLUCOSE THERASENSE, INC. 2002-10-08 — — US disclosed
US-6338790-B1 DETECTION OF BIOANALYTES IN A SMALL VOLUME SAMPLE; CONCENTRATION OF A BIOMOLECULE, SUCH AS GLUCOSE OR LACTATE, USING TECHNIQUES SUCH AS COULOMETRY, AMPEROMETRY, AND POTENTIOMETRY. AN ENZYME CAPABLE OF CATALYZING THE THERASENSE, INC. 2002-01-15 — — US disclosed
US-6299757-B1 ANALYTICAL SENSORS FOR THE DETECTION OF BIOANALYTES; ESPECIALLY MONITORING GLUCOSE LEVELS IN DIABETIC PATIENTS THERASENSE, INC. 2001-10-09 — — US disclosed
EP-1119637-A1 SMALL VOLUME $i(IN VITRO) ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR Therasense, Inc. (US) 2001-08-01 — — EP disclosed
EP-0885183-B1 PROCESS FOR PRODUCING ALDEHYDES BY HYDROFORMYLATION OF OLEFINS BASF AG (DE) 2001-06-20 — — EP disclosed
US-6107524-A Process for producing aldehydes by hydroformylation of olefins BASF AKTIENGESELLSCHAFT (DE) 2000-08-22 — — US disclosed
WO-2000020626-A1 SMALL VOLUME IN VITRO ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR THERASENSE, INC. (US) 2000-04-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078116-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, MCL1 ALDH1A1 3887/4885KDM4E 1954/4885CHRM5 4875/4885
US-20260109696-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS KRAS, MYC, NRAS ALDH1A1 3241/4885KDM4E 2660/4885CHRM5 4836/4885
US-20250074925-A1 RARE EARTH COMPLEX L1CAM, CHRM1, NPM1 ALDH1A1 2286/4885KDM4E 4590/4885CHRM5 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.